Open day at the ISAE-SUPAERO campus
9.10.2018 11:00:00 EEST | Business Wire | Press release
As part of the Science Fair, organized this year around the theme of 'popular opinion', the ISAE-SUPAERO will open its entire campus to the public on Saturday, October 13 from 10.00 to 18.00. The event is aimed at families, businesses, partners, journalists or alumni (former students) and more than 3,000 people are expected to attend.
Several discussions will take place throughout the day to explain and debunk popular opinion with the general public: "Mechanics is not for girls", "We use only 10% of our brain", "Robots are smart", "Digital simulation is only for geeks", "Astronauts float because there's no gravity", "Laser beams are only used for fighting in science fiction movies", "Aircraft engines pollute the atmosphere and they're noisy", and many more.
Programme at the ISAE-SUPAERO:
➢ Lab visits and scientific demonstrations
➢ Tour of the aero-acoustic wind tunnel - the only facility of its kind in Europe
➢ Demonstrations
➢ Meetings with student clubs
➢ Activities for children
➢ Conference on "How does this aircraft fly safely?"
➢ "My student life at ISAE-SUPAERO" tour with an overview of the engineering curriculum, presentation of digital learning and guided tours of the student campus, sports facilities, residences and the university restaurant
➢ Boutique for kids: a chance to buy ISAE-SUPAERO souvenirs
➢ Show by the student band, Los Soupaéros
Practical information
Free entry - Address: 10 avenue Edouard Belin, 31055 Toulouse. Ring road (Rocade) exit 20. No parking in the vicinity; please use public transport (bus no. 27 and 37, get off at 'Laas CNRS' or 'Supaero'; Metro station 'Faculté de Pharmacie'). ID required for admission. Entrance on avenue Colonel Roche or avenue Edouard Belin. VélôToulouse stations nearby. Drinks and on-site catering available.
About the ISAE-SUPAERO
Global leader in higher education for aerospace engineering, ISAE-SUPAERO offers a unique range of training at the highest level: ISAE-SUPAERO engineer, CNAM-ISAE apprenticeship engineer, Master of Science in "Aerospace Engineering" (in English), 5 research-oriented master degrees, 15 specialized master degrees, 6 doctoral programs. The ISAE-SUPAERO learning community consists of more than 100 full-time professors and researchers and 1,700 students and doctoral students; it also relies on 1,800 lecturers from the professional world. More than 30% of its 650 annual graduates are international students. Its alumni network has more than 21,500 alumni on all continents.
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181009005484/en/
Contact information
OXYGEN TOULOUSE
Cécile MATHEY
cecilem@oxygen-rp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 15:00:00 EET | Press release
Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end workflows spanning onboarding, KYC, AML, fraud, underwriting, payments, disputes, servicing, and collections. For
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom